Company: BDRX
Filing Date: 2025-12-11
Form Type: F-1/A
Source: 0001214659-25-017944
Chunk: 11

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-11
Form: F-1/A
Chunk 11
---
 |

On July 31, 2025, we effected
a ratio change in the number of Ordinary Shares represented by our Depositary Shares from 10,000 Ordinary Shares per Depositary Share
to 100,000 Ordinary Shares per Depositary Share. No fractional Depositary Shares were issued.

The change in the number of
Ordinary Shares resulting from the reverse stock split and change in the number of Depositary Shares (and the underlying Ordinary Shares)
resulting from the change in ratio, including any changes resulting from fractional Depositary Shares not being issued to holders in connection
with the Depositary Share ratio change, has been applied retroactively to all share and per share amounts presented in this prospectus,
to the extent applicable. As a result of retroactively applying changes resulting from fractional Depositary Shares not being issued to
holders in connection with the Depositary Share ratio change, the amount of Ordinary Shares issued in prior transactions may not equal
the amount of Depositary Shares such Depositary Shares are currently exercisable for.

| 3 |

<div align='center'>MARKET AND INDUSTRY DATA</div>

This prospectus contains estimates,
projections and other information concerning our industry, our business and the market for our product candidates. Information that is
based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties, and actual
events or circumstances may differ materially from events and circumstances that are assumed in this information. Unless otherwise expressly
stated, we obtained this industry, business, market and other data from our own internal estimates and research as well as from reports,
research surveys, studies and similar data prepared by market research firms and other third parties, industry, medical and general publications,
government data and similar sources. While we believe our internal company research as to such matters is reliable and the market definitions
are appropriate, neither such research nor these definitions have been verified by any independent source.

In addition, assumptions and
estimates of our and our industry’s future performance are necessarily subject to a high degree of uncertainty and risk due to a
variety of factors, including those described in the section titled “Risk Factors.” These and other factors could cause
our future performance to differ materially from our assumptions and estimates. See “Cautionary Note Regarding Forward-Looking Statements.”

<div align='center'>WEBSITE DISCLAIMER</div>

We maintain a public website
at https://www.biodexapharma.com and use our website as a route channel of distribution of company information, including